Cargando…

Biophysical characterization and crystal structure of the Feline Immunodeficiency Virus p15 matrix protein

BACKGROUND: Feline Immunodeficiency Virus (FIV) is a viral pathogen that infects domestic cats and wild felids. During the viral replication cycle, the FIV p15 matrix protein oligomerizes to form a closed matrix that underlies the lipidic envelope of the virion. Because of its crucial role in the ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Serrière, Jennifer, Robert, Xavier, Perez, Magali, Gouet, Patrice, Guillon, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706335/
https://www.ncbi.nlm.nih.gov/pubmed/23800358
http://dx.doi.org/10.1186/1742-4690-10-64
_version_ 1782476537853902848
author Serrière, Jennifer
Robert, Xavier
Perez, Magali
Gouet, Patrice
Guillon, Christophe
author_facet Serrière, Jennifer
Robert, Xavier
Perez, Magali
Gouet, Patrice
Guillon, Christophe
author_sort Serrière, Jennifer
collection PubMed
description BACKGROUND: Feline Immunodeficiency Virus (FIV) is a viral pathogen that infects domestic cats and wild felids. During the viral replication cycle, the FIV p15 matrix protein oligomerizes to form a closed matrix that underlies the lipidic envelope of the virion. Because of its crucial role in the early and late stages of viral morphogenesis, especially in viral assembly, FIV p15 is an interesting target in the development of potential new therapeutic strategies. RESULTS: Our biochemical study of FIV p15 revealed that it forms a stable dimer in solution under acidic conditions and at high concentration, unlike other retroviral matrix proteins. We determined the crystal structure of full-length FIV p15 to 2 Å resolution and observed a helical organization of the protein, typical for retroviral matrix proteins. A hydrophobic pocket that could accommodate a myristoyl group was identified, and the C-terminal end of FIV p15, which is mainly unstructured, was visible in electron density maps. As FIV p15 crystallizes in acidic conditions but with one monomer in the asymmetric unit, we searched for the presence of a biological dimer in the crystal. No biological assembly was detected by the PISA server, but the three most buried crystallographic interfaces have interesting features: the first one displays a highly conserved tryptophan acting as a binding platform, the second one is located along a 2-fold symmetry axis and the third one resembles the dimeric interface of EIAV p15. Because the C-terminal end of p15 is involved in two of these three interfaces, we investigated the structure and assembly of a C-terminal-truncated form of p15 lacking 14 residues. The truncated FIV p15 dimerizes in solution at a lower concentration and crystallizes with two molecules in the asymmetric unit. The EIAV-like dimeric interface is the only one to be retained in the new crystal form. CONCLUSION: The dimeric form of FIV p15 in solution and its extended C-terminal end are characteristic among lentiviral matrix proteins. Crystallographic interfaces revealed several interactions that might be involved in FIV replication. Further studies are needed to better understand their biological relevance in the function of FIV Gag during viral replication.
format Online
Article
Text
id pubmed-3706335
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37063352013-07-10 Biophysical characterization and crystal structure of the Feline Immunodeficiency Virus p15 matrix protein Serrière, Jennifer Robert, Xavier Perez, Magali Gouet, Patrice Guillon, Christophe Retrovirology Research BACKGROUND: Feline Immunodeficiency Virus (FIV) is a viral pathogen that infects domestic cats and wild felids. During the viral replication cycle, the FIV p15 matrix protein oligomerizes to form a closed matrix that underlies the lipidic envelope of the virion. Because of its crucial role in the early and late stages of viral morphogenesis, especially in viral assembly, FIV p15 is an interesting target in the development of potential new therapeutic strategies. RESULTS: Our biochemical study of FIV p15 revealed that it forms a stable dimer in solution under acidic conditions and at high concentration, unlike other retroviral matrix proteins. We determined the crystal structure of full-length FIV p15 to 2 Å resolution and observed a helical organization of the protein, typical for retroviral matrix proteins. A hydrophobic pocket that could accommodate a myristoyl group was identified, and the C-terminal end of FIV p15, which is mainly unstructured, was visible in electron density maps. As FIV p15 crystallizes in acidic conditions but with one monomer in the asymmetric unit, we searched for the presence of a biological dimer in the crystal. No biological assembly was detected by the PISA server, but the three most buried crystallographic interfaces have interesting features: the first one displays a highly conserved tryptophan acting as a binding platform, the second one is located along a 2-fold symmetry axis and the third one resembles the dimeric interface of EIAV p15. Because the C-terminal end of p15 is involved in two of these three interfaces, we investigated the structure and assembly of a C-terminal-truncated form of p15 lacking 14 residues. The truncated FIV p15 dimerizes in solution at a lower concentration and crystallizes with two molecules in the asymmetric unit. The EIAV-like dimeric interface is the only one to be retained in the new crystal form. CONCLUSION: The dimeric form of FIV p15 in solution and its extended C-terminal end are characteristic among lentiviral matrix proteins. Crystallographic interfaces revealed several interactions that might be involved in FIV replication. Further studies are needed to better understand their biological relevance in the function of FIV Gag during viral replication. BioMed Central 2013-06-24 /pmc/articles/PMC3706335/ /pubmed/23800358 http://dx.doi.org/10.1186/1742-4690-10-64 Text en Copyright © 2013 Serrière et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Serrière, Jennifer
Robert, Xavier
Perez, Magali
Gouet, Patrice
Guillon, Christophe
Biophysical characterization and crystal structure of the Feline Immunodeficiency Virus p15 matrix protein
title Biophysical characterization and crystal structure of the Feline Immunodeficiency Virus p15 matrix protein
title_full Biophysical characterization and crystal structure of the Feline Immunodeficiency Virus p15 matrix protein
title_fullStr Biophysical characterization and crystal structure of the Feline Immunodeficiency Virus p15 matrix protein
title_full_unstemmed Biophysical characterization and crystal structure of the Feline Immunodeficiency Virus p15 matrix protein
title_short Biophysical characterization and crystal structure of the Feline Immunodeficiency Virus p15 matrix protein
title_sort biophysical characterization and crystal structure of the feline immunodeficiency virus p15 matrix protein
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706335/
https://www.ncbi.nlm.nih.gov/pubmed/23800358
http://dx.doi.org/10.1186/1742-4690-10-64
work_keys_str_mv AT serrierejennifer biophysicalcharacterizationandcrystalstructureofthefelineimmunodeficiencyvirusp15matrixprotein
AT robertxavier biophysicalcharacterizationandcrystalstructureofthefelineimmunodeficiencyvirusp15matrixprotein
AT perezmagali biophysicalcharacterizationandcrystalstructureofthefelineimmunodeficiencyvirusp15matrixprotein
AT gouetpatrice biophysicalcharacterizationandcrystalstructureofthefelineimmunodeficiencyvirusp15matrixprotein
AT guillonchristophe biophysicalcharacterizationandcrystalstructureofthefelineimmunodeficiencyvirusp15matrixprotein